TEVA Trademark

Trademark Overview


On Tuesday, October 20, 2020, a trademark application was filed for TEVA with the United States Patent and Trademark Office. The USPTO has given the TEVA trademark a serial number of 90266118. The federal status of this trademark filing is REGISTERED as of Tuesday, December 19, 2023. This trademark is owned by Teva Pharmaceutical Industries Ltd.. The TEVA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ...
teva

General Information


Serial Number90266118
Word MarkTEVA
Filing DateTuesday, October 20, 2020
Status700 - REGISTERED
Status DateTuesday, December 19, 2023
Registration Number7249759
Registration DateTuesday, December 19, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 16, 2021

Trademark Statements


Description of MarkThe mark consists of two curved band designs that begins at the bottom center of an outlined rectangle and rise up toward the upper right hand corner of the rectangle. In the center of the curved band design is a large circle with an outline around the left side. In the bottom right hand corner is the word ''TEVA'' in lower case letters. The ''V'' in the word ''TEVA'' is formed by 2 leaf shapes. The entire mark is outlined by a thin line in the shape of a rectangle.
Goods and ServicesPharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system
Translation of Words in MarkThe English translation of the word "TEVA" in the mark is "nature".

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 8, 2020
Primary Code005
First Use Anywhere DateFriday, November 1, 2013
First Use In Commerce DateFriday, November 1, 2013

Trademark Owner History


Party NameTeva Pharmaceutical Industries Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressTel Aviv 6944020
IL

Party NameTeva Pharmaceutical Industries Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressTel Aviv 6944020
IL

Party NameTeva Pharmaceutical Industries Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressJerusalem 91010
IL

Trademark Events


Event DateEvent Description
Tuesday, December 19, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 19, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, November 14, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, November 13, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, November 13, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, November 8, 2023USE AMENDMENT FILED
Wednesday, November 8, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, May 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 28, 2023SOU EXTENSION 4 GRANTED
Friday, April 28, 2023SOU EXTENSION 4 FILED
Friday, April 28, 2023SOU TEAS EXTENSION RECEIVED
Friday, November 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 2, 2022SOU EXTENSION 3 GRANTED
Wednesday, November 2, 2022SOU EXTENSION 3 FILED
Wednesday, November 2, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, May 17, 2022SOU EXTENSION 3 DENIAL LETTER PREPARED
Tuesday, May 17, 2022SOU EXTENSION 3 DENIAL LETTER PREPARED
Tuesday, May 17, 2022SOU EXTENSION 3 FILED
Tuesday, May 17, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 10, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, May 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 9, 2022SOU EXTENSION 2 GRANTED
Monday, May 9, 2022SOU EXTENSION 2 FILED
Monday, May 9, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, November 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 5, 2021SOU EXTENSION 1 GRANTED
Friday, November 5, 2021SOU EXTENSION 1 FILED
Friday, November 5, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, May 11, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 16, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 16, 2021PUBLISHED FOR OPPOSITION
Wednesday, February 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 9, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 9, 2021EXAMINER'S AMENDMENT ENTERED
Tuesday, February 9, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 9, 2021EXAMINERS AMENDMENT E-MAILED
Tuesday, February 9, 2021EXAMINERS AMENDMENT -WRITTEN
Friday, February 5, 2021ASSIGNED TO EXAMINER
Wednesday, December 9, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, December 8, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 23, 2020NEW APPLICATION ENTERED